Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Pneumonia × Thoracic × Clear all

Phase

Status

Completed 8 Recruiting 6 Unknown 4 Not yet recruiting 4 Terminated 2 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 16 Neoplasms 7 Mesothelioma 4 Colorectal Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Mesothelioma, Malignant 3 Prostatic Neoplasms 2 Endometrial Neoplasms 2 Diabetes Mellitus 2 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Psoriasis 1 Post-Lyme Disease Syndrome 1 Pneumonia 1 Parkinson Disease 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Obsessive-Compulsive Disorder 1 Neoplasms, Squamous Cell 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 NSCLC 1 Myasthenia Gravis 1 Multiple Sclerosis, Relapsing-Remitting 1 Multiple Sclerosis, Chronic Progressive 1 Multiple Sclerosis 1

Interventions

Prednisone 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡